 |
PDBsum entry 1p14
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
278:26007-26014
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural and biochemical evidence for an autoinhibitory role for tyrosine 984 in the juxtamembrane region of the insulin receptor.
|
|
S.Li,
N.D.Covino,
E.G.Stein,
J.H.Till,
S.R.Hubbard.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Tyrosine 984 in the juxtamembrane region of the insulin receptor, between the
transmembrane helix and the cytoplasmic tyrosine kinase domain, is conserved
among all insulin receptor-like proteins from hydra to humans. Crystallographic
studies of the tyrosine kinase domain and proximal juxtamembrane region reveal
that Tyr-984 interacts with several other conserved residues in the N-terminal
lobe of the kinase domain, stabilizing a catalytically nonproductive position of
alpha-helix C. Steady-state kinetics measurements on the soluble kinase domain
demonstrate that replacement of Tyr-984 with phenylalanine results in a 4-fold
increase in kcat in the unphosphorylated (basal state) enzyme. Moreover,
mutation of Tyr-984 in the full-length insulin receptor results in significantly
elevated receptor phosphorylation levels in cells, both in the absence of
insulin and following insulin stimulation. These data demonstrate that Tyr-984
plays an important structural role in maintaining the quiescent, basal state of
the insulin receptor. In addition, the structural studies suggest a possible
target site for small molecule activators of the insulin receptor, with
potential use in the treatment of noninsulin-dependent diabetes mellitus.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIG. 2. Crystal structure of IRKD1132N. A, 2F[o] - F[c]
electron density map (1.9 Å resolution, 1 contour)
is shown in wire mesh (purple) in the region of Tyr-984. The
superimposed refined structure of IRKD1132N is shown in stick
representation, with the proximal juxtamembrane region (residues
978-988) colored orange, residues in C colored yellow, and
residues in the sheet (and connecting
loops) colored cyan. Ordered water molecules are indicated with
red spheres. Selected residues are labeled. B, ribbon diagram of
the IRKD1132N structure. strands are colored
cyan, and -helices are colored
yellow. The proximal juxtamembrane region including Tyr-984 is
colored orange, with the side chain of Tyr-984 shown in
ball-and-stick representation, and C in the N-terminal
lobe is labeled. The dashed gray line indicates that the
activation loop is disordered (from Met-1153 through Leu-1171).
The N and C termini are denoted by N and C.
|
 |
Figure 3.
FIG. 3. Conformation of the proximal juxtamembrane region
in IRK. Stereo views of the proximal juxtamembrane region and
the N-terminal kinase lobe from the IRKD1132N structure (A) and
the tris-phosphorylated IRKY984F structure (13) (B) are shown.
The view is from above with respect to the view in Fig. 3. The
juxtamembrane region is shown in ball-and-stick representation
with carbon atoms colored orange, nitrogen atoms colored blue,
and oxygen atoms colored red. The side chains of selected
residues of the N-terminal kinase lobe are shown in ball-
and-stick representation with carbon atoms colored gray,
nitrogen atoms colored blue, and oxygen atoms colored red.
Semi-transparent van der Waals' surfaces in A indicate
hydrophobic packing of Tyr-984 with Leu-1045 and Val-1065. C,
schematic diagram (approximate spatial layout) showing the
invariant residues in the insulin receptor subfamily that form
the Tyr-984 binding pocket. The residue labels are placed
alongside the C atoms of the side
chains. The backbone nitrogen atoms of Trp-989 and Ser-1067 are
included as well as the carbonyl oxygen of nonconserved Val-985
(dark gray). Hydrogen bonds are depicted by dashed lines, and
van der Waals' interactions (<3.8 Å) with Tyr-984 are
depicted as concentric half-circles.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
26007-26014)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.M.Zhang,
X.Yu,
M.J.Greig,
K.S.Gajiwala,
J.C.Wu,
W.Diehl,
E.A.Lunney,
M.R.Emmett,
and
A.G.Marshall
(2010).
Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometry.
|
| |
Protein Sci,
19,
703-715.
|
 |
|
|
|
|
 |
W.W.Chen,
M.Niepel,
and
P.K.Sorger
(2010).
Classic and contemporary approaches to modeling biochemical reactions.
|
| |
Genes Dev,
24,
1861-1875.
|
 |
|
|
|
|
 |
A.Chase,
B.Schultheis,
S.Kreil,
J.Baxter,
C.Hidalgo-Curtis,
A.Jones,
L.Zhang,
F.H.Grand,
J.V.Melo,
and
N.C.Cross
(2009).
Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1.
|
| |
Leukemia,
23,
358-364.
|
 |
|
|
|
|
 |
C.W.Ward,
and
M.C.Lawrence
(2009).
Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor.
|
| |
Bioessays,
31,
422-434.
|
 |
|
|
|
|
 |
H.J.Tsai,
and
S.Y.Chou
(2009).
A novel hydroxyfuroic acid compound as an insulin receptor activator structure and activity relationship of a prenylindole moiety to insulin receptor activation.
|
| |
J Biomed Sci,
16,
68.
|
 |
|
|
|
|
 |
R.V.Rajala,
and
A.Rajala
(2009).
Cytoskeletal components enhance the autophosphorylation of retinal insulin receptor.
|
| |
Chem Biol Interact,
180,
245-253.
|
 |
|
|
|
|
 |
J.Wu,
Y.D.Tseng,
C.F.Xu,
T.A.Neubert,
M.F.White,
and
S.R.Hubbard
(2008).
Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2.
|
| |
Nat Struct Mol Biol,
15,
251-258.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.P.Craddock,
C.Cotter,
and
W.T.Miller
(2007).
Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region.
|
| |
FEBS Lett,
581,
3235-3240.
|
 |
|
|
|
|
 |
J.Ishiko,
M.Mizuki,
I.Matsumura,
H.Shibayama,
H.Sugahara,
G.Scholz,
H.Serve,
and
Y.Kanakura
(2005).
Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant.
|
| |
Oncogene,
24,
8144-8153.
|
 |
|
|
|
|
 |
S.Li,
R.S.Depetris,
D.Barford,
J.Chernoff,
and
S.R.Hubbard
(2005).
Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase.
|
| |
Structure,
13,
1643-1651.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.J.Dibb,
S.M.Dilworth,
and
C.D.Mol
(2004).
Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
|
| |
Nat Rev Cancer,
4,
718-727.
|
 |
|
|
|
|
 |
S.R.Hubbard
(2004).
Juxtamembrane autoinhibition in receptor tyrosine kinases.
|
| |
Nat Rev Mol Cell Biol,
5,
464-471.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |